Allosteric modulation of adenosine receptors

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 5, 2011, Pages 1309-1318

  Göblyös, Anikó ^a   Ijzerman, Ad P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adenosine receptor; Allosteric modulation; Hybrid allo orthosteric ligand; LUF5485; LUF6000; LUF6096; PD81,723

Indexed keywords

(2 AMINO 4,5,6,7 TETRAHYDROBENZO[B]THIOPHEN 3 YL) (2 CHLOROPHENYL)METHANONE; (2 AMINO 4,5,6,7 TETRAHYDROBENZO[B]THIOPHEN 3 YL) (4 CHLOROPHENYL)METHANONE; (2 AMINO 6 BENZYL 4,5,6,7 TETRAHYDROTHIENO[2,3 C]PYRIDIN 3 YL) (4 CHLOROPHENYL)METHANONE; 2 AMINO 3 (3 CHLOROBENZOYL) 4,5,6,7 TETRAHYDROBENZO[B]THIOPHENE; 2 AMINO 3 (3,4 DICHLOROBENZOYL) 4,5,6,7 TETRAHYDROBENZO[B]THIOPHENE; 2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; 2 AMINO 6 BENZYL 3 (4 CHLOROBENZOYL) 4,5,6,7 TETRAHYDROTHIENO[2,3 C]PYRIDINE; 4 ANILINO 2 CYCLOPENTYLIMIDAZO[4,5 C]QUINOLINE; 4 METHOXY N [7 METHYL 3 (2 PYRIDINYL) 1 ISOQUINOLINYL]BENZAMIDE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; AMILORIDE DERIVATIVE; LUF 6000; LUF 6096; N (2,3 DIPHENYL 1,2,4 THIADIAZOL 5(2H) YLIDENE)METHANAMINE; N (3,4 DICHLOROPHENYL) 2 CYCLOHEXYL 1H IMIDAZO[4,5 C]QUINOLIN 4 AMINE; N [2 [(3,4 DICHLOROPHENYL)AMINO]QUINOLIN 4 YL]CYCLOHEXANECARBOXAMIDE; T 62; UNCLASSIFIED DRUG;

ALLOSTERISM; ANALGESIC ACTIVITY; ARTICLE; BINDING SITE; DRUG ACTIVITY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ALLOSTERIC REGULATION; ALLOSTERIC SITE; ANIMALS; HUMANS; RECEPTORS, PURINERGIC P1;

EID: 79953224436     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.06.013     Document Type: Review

References (67)

1. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors Pharmacol. Rev. 53 2001 527 552 (Pubitemid 33136237)
2. T.W. Schwartz, and B. Holst Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Trends Pharmacol. Sci. 28 2007 366 373 (Pubitemid 47087971)
3. W. Soudijn, I. van Wijngaarden, and A.P. IJzerman Allosteric modulation of G protein-coupled receptors: perspectives and recent developments Drug Discov. Today 9 2004 752 758 (Pubitemid 39140802)
4. W. Soudijn, I. van Wijngaarden, and A.P. IJzerman Allosteric modulation of G protein-coupled receptors Curr. Opin. Drug Discov. Dev. 5 2002 749 755 (Pubitemid 36253794)
5. L.T. May, K. Leach, P.M. Sexton, and A. Christopoulos Allosteric modulation of G protein-coupled receptors Annu. Rev. Pharmacol. Toxicol. 47 2007 1 51 (Pubitemid 46277033)
6. Z.-G. Gao, and K.A. Jacobson Allosterism in membrane receptors Drug Discov. Today 11 2006 191 202
7. J.A. Lewis, E.P. Lebois, and C.W. Lindsley Allosteric modulation of kinases and GPCRs: design principles and structural diversity Curr. Opin. Chem. Biol. 12 2008 269 280
8. K.A. Jacobson, and Z.-G. Gao Adenosine receptors as therapeutic targets Nat. Rev. Drug Discov. 5 2006 247 264 (Pubitemid 43336037)
9. Z.-G. Gao, S.-K. Kim, A.P. IJzerman, and K.A. Jacobson Allosteric modulation of the adenosine family of receptors Mini Rev. Med. Chem. 5 2005 545 553 (Pubitemid 40754168)
10. 1 adenosine receptor Mini Rev. Med. Chem. 7 2007 559 569 (Pubitemid 47099177)
11. A. Göblyös, and A.P. IJzerman Allosteric modulation of adenosine receptors Purinergic Signal. 5 2009 51 61
12. 1 receptor binding by 2-amino-3-benzoylthiophenes Mol. Pharmacol. 38 1990 950 958
13. 1 receptor binding and function by 2-amino-3-benzoylthiophenes Mol. Pharmacol. 38 1990 939 949
14. F.J. Tinney, J.P. Sanchez, and J.A. Nogas Synthesis and pharmacological evaluation of 2, 3-dihydro-1H-thieno[2, 3-e][1, 4]diazepines J. Med. Chem. 17 1974 624 630
15. 1 receptor: synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding J. Med. Chem. 42 1999 3629 3635 (Pubitemid 29445096)
16. 1 receptors Drug Dev. Res. 49 2000 227 237 (Pubitemid 30418419)
17. 1 adenosine receptor Bioorg. Med. Chem. Lett. 10 2000 1953 1957 (Pubitemid 30663348)
18. 1 adenosine receptor J. Med. Chem. 46 2003 794 809 (Pubitemid 36258870)
19. 1 receptor Eur. J. Med. Chem. 39 2004 855 865 (Pubitemid 39298442)
20. R. Romagnoli, P.G. Baraldi, A.R. Moorman, M.A. Iaconinoto, M.D. Carrion, C.L. Cara, M.A. Tabrizi, D. Preti, F. Fruttarolo, S.P. Baker, K. Varani, and P.A. Borea Microwave-assisted synthesis of thieno[2, 3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A1 receptor Bioorg. Med. Chem. 16 2006 5530 5533 (Pubitemid 44415461)
21. 1 adenosine receptor J. Med. Chem. 51 2008 5875 5879
22. C.E. Tranberg, A. Zickgraf, B.N. Giunta, H. Lütjens, H. Figler, L.J. Merphree, R. Falke, H. Fleischer, J. Linden, P.J. Scammells, and R.A. Olsson 2-Amino-3-aroyl-4, 5-alkylthiopenes: agonist allosteric enhancers at human A1 adenosine receptors J. Med. Chem. 45 2002 382 389 (Pubitemid 34073455)
23. 1 adenosine agonist binding: new 3-, 4-, and 5-modifications J. Med. Chem. 46 2003 1870 1877 (Pubitemid 36532230)
24. 1 receptor allosteric enhancers Bioorg. Med. Chem. 14 2006 2358 2365 (Pubitemid 43254745)
25. 1 adenosine receptor binding Org. Biomol. Chem. 5 2007 1276 1281 (Pubitemid 46543586)
26. 1 adenosine receptor allosteric enhancers Bioorg. Med. Chem. 16 2008 1319 1327 (Pubitemid 351191773)
27. 1 receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3- benzoylthiophenes J. Med. Chem. 52 2009 4543 4547
28. R. Romagnoli Synthesis and biological characterization of [3H](2-amino-4, 5, 6, 7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancer Bioorg. Med. Chem. 16 2006 1402 1404 (Pubitemid 43143030)
29. 1 receptor modulators and antagonists J. Med. Chem. 51 2008 6165 6172
30. L. Aurelio, C. Valant, H. Figler, B.L. Flynn, J. Linden, P.M. Sexton, A. Christopoulos, and P.J. Scammells 3- and 6-Substituted 2-amino-4, 5, 6, 7-tetrahydrothieno[2, 3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists Bioorg. Med. Chem. 17 2009 7353 7361
31. 1 adenosine receptors Bioorg. Med. Chem. Lett. 12 2002 1563 1566 (Pubitemid 34569243)
32. A. Göblyös, S.N. Santiago, D. Pietra, T. Mulder-Krieger, J. von Frijtag Drabbe Künzel, J. Brussee, and A.P. IJzerman Synthesis and biological evaluation of 2-aminothiazoles and their amide derivatives on human adenosine receptors. Lack of effect of 2-aminothiazoles as allosteric enhancers Bioorg. Med. Chem. 13 2005 2079 2087 (Pubitemid 40261128)
33. M.D. Chordia, M. Zigler, L.J. Murphree, H. Figler, T.L. Macdonald, R.A. Olsson, and J. Linden 6-Aryl-8H-indeno[1, 2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency J. Med. Chem. 48 2005 5131 5139 (Pubitemid 41113901)
34. A.B. Fawzi, D. Macdonald, L.L. Benbow, A. Smith-Torhan, H. Zhang, B.C. Weig, G. Ho, D. Tulshian, M.E. Linder, and M.P. Graziano SCH-202676: an allosteric modulator of both agonist and antagonist binding to G protein-coupled receptors Mol. Pharmacol. 59 2001 30 37 (Pubitemid 32043082)
35. A.M.C.H. van den Nieuwendijk, D. Pietra, L. Heitman, A. Göblyös, and A.P. IJzerman Synthesis and biological evaluation of 2, 3, 5-substituted [1, 2, 4]thiadiazoles as allosteric modulators of adenosine receptors J. Med. Chem. 47 2004 663 672 (Pubitemid 38129723)
36. A. Göblyös, H. de Vries, J. Brussee, and A.P. IJzerman Synthesis and biological evaluation of a new series of 2, 3, 5-substituted [1, 2, 4]thiadiazoles as modulators of adenosine A1 receptors and their molecular mechanism of action J. Med. Chem. 48 2005 1145 1151 (Pubitemid 40270456)
37. 2-adrenergic receptors by sodium J. Biol. Chem. 265 1990 21590 21595 (Pubitemid 120014201)
38. 1 receptors in calf brain Biochem. Pharmacol. 40 1990 827 834 (Pubitemid 20246592)
39. 1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride Biochem. Pharmacol. 40 1990 835 842 (Pubitemid 20246593)
40. 3 adenosine receptors Biochem. Pharmacol. 65 2003 525 534 (Pubitemid 36144237)
41. 2A adenosine receptors by amiloride analogues and sodium ions Biochem. Pharmacol. 60 2000 669 676 (Pubitemid 30604249)
42. 6-1, 3-Diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A2A adenosine receptors Eur. J. Med. Chem. 43 2008 1639 1647
43. 2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity J. Med. Chem. 52 2009 3994 4006
44. 3 adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives Mol. Pharmacol. 60 2001 1057 1063 (Pubitemid 33027441)
45. 3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives J. Med. Chem. 41 1998 3987 3993 (Pubitemid 28483476)
46. P.J.M. van Galen, P. Nissen, I. van Wijngaargen, A.P. IJzerman, and W. Soudijn 1H-Imidazo[4, 5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists J. Med. Chem. 34 1991 1202 1206
47. 3 adenosine receptors by a series of imidazoquinoline derivatives Mol. Pharmacol. 62 2002 81 89 (Pubitemid 34680519)
48. J.G. Topliss Utilization of operational schemes for analog synthesis in drug design J. Med. Chem. 15 1972 1006 1011
49. A. Göblyös, Z.-G. Gao, J. Brussee, R. Connestari, S.N. Santiago, K. Ye, A.P. IJzerman, and K.A. Jacobson Structure-activity relationships of new 1H-imidazo[4, 5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor J. Med. Chem. 49 2006 3354 3361 (Pubitemid 43830533)
50. Y. Kim, S. de Castro, Z.-G. Gao, A.P. IJzerman, and K.A. Jacobson Novel 2- and 4-substituted 1H-Imidazo[4, 5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor J. Med. Chem. 52 2009 2098 2108
51. 3 adenosine receptor by an imidazoquinoline allosteric enhancer LUF6000 BMC Pharmacol. 8 2008 20 30
52. L.H. Heitman, A. Göblyös, A.M. Zweemer, R. Bakker, T. Mulder-Krieger, J.P.D. van Veldhoven, H. de Vries, J. Brussee, and A.P. IJzerman A series of 2, 4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor J. Med. Chem. 52 2009 926 931
53. 3 adenosine receptor Biochem. Pharmacol. 79 2010 48 56
54. S. Bhattacharya, R.L. Youkey, K. Ghartey, M. Leonard, J. Linden, and A.L. Tucker The allosteric enhancer PD 81, 723 increases chimaeric A1/A2A adenosine receptor coupling with Gs Biochem. J. 396 2006 139 146 (Pubitemid 43764505)
55. R.A.F. Ligt, S.A. Rivkees, A. Lorenzen, R. Leurs, and A.P. IJzerman A "locked-on", constitutively active mutant of the adenosine A1 receptor Eur. J. Pharmacol. 510 2005 1 8 (Pubitemid 40312383)
56. A. Kourounakis, C. Visser, M. de Groote, and A.P. IJzerman Differential effects of the allosteric enhancer (2-amino-4, 5-dimethyl-trienyl)[3- (trifluoromethyl)phenyl]-methanone (PD 81, 723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor Biochem. Pharmacol. 61 2001 137 144 (Pubitemid 32121778)
57. 1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding Mol. Pharmacol. 50 1996 1635 1642 (Pubitemid 26425121)
58. 2A adenosine receptors: involvemement of Glu(13) and His(278) in ligand binding and sodium modulation Biochem. Pharmacol. 60 2000 661 668 (Pubitemid 30604248)
59. 3 adenosine receptor Mol. Pharmacol. 63 2003 1021 1031 (Pubitemid 36529920)
60. 2A adenosine receptor bound to an antagonist Science 322 2008 1211 1217
61. 1 receptor J. Med. Chem. 53 2010 3028 3037
62. T.J.H. Bueters, H.P.M. Helden, M. Danhof, and A.P. IJzerman Effects of the adenosine A1 receptor allosteric modulators PD 81, 723 and LUF5484 on the striatal acetylcholine release Eur. J. Pharmacol. 454 2002 177 182 (Pubitemid 35287476)
63. T. Mizumura, J.A. Auchampach, J. Linden, R.F. Bruns, and G.J. Gross PD 81, 723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs Circ. Res. 79 1996 415 423 (Pubitemid 26276902)
64. X. Li, D. Conklin, W. Ma, X. Zhu, and J.C. Eisenach Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain Pain 97 2002 117 125 (Pubitemid 34603315)
65. X. Li, D. Conklin, H.-L. Pan, and J.C. Eisenach Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism J. Pharmacol. Exp. Ther. 305 2003 950 955 (Pubitemid 36617972)
66. H. Obata, X. Li, and J.C. Eisenach Spinal adenosine receptor activation reduces hypersensitivity after surgery by a different mechanism than after nerve injury Anesthesiology 100 2004 1258 1262 (Pubitemid 38541983)
67. 1 adenosine receptor antagonists, agonists and allosteric enhancers C.N. Wilson, S.J. Mustafa, Adenosine Receptors in Health and Disease, Handbook of Experimental Pharmacology 2009 Springer-Verlag Berlin Heidelberg 25 58